TY - JOUR
T1 - Longitudinal Associations Between COVID-19 Stress and the Mental Health of Children With ADHD
AU - Summerton, Ainsley
AU - Bellows, Susannah T.
AU - Westrupp, Elizabeth M.
AU - Stokes, Mark A.
AU - Coghill, David
AU - Bellgrove, Mark A.
AU - Hutchinson, Delyse
AU - Becker, Stephen P.
AU - Melvin, Glenn
AU - Quach, Jon
AU - Efron, Daryl
AU - Stringaris, Argyris
AU - Middeldorp, Christel M.
AU - Banaschewski, Tobias
AU - Sciberras, Emma
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding support for this project was provided through the Centre for Social and Early Emotional Development, a Strategic Research Centre of the Office of the Deputy Vice Chancellor Research, Deakin University Australia. A/Prof Sciberras is currently supported by an Australian Medical Research Future Fund Investigator Grant (#1194297) and was previously funded by an Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship (1110688) and a veski Inspiring Women’s Fellowship. A/Prof Quach receives funding from the AXA Research Impact Fund. A/Prof Efron was supported by a Clinician Scientist Fellowship from the Murdoch Children’s Research Institute (MCRI). A/Prof Hutchinson was supported by a NHMRC Investigator Grant (1197488). MCRI is supported by the Victorian Government’s Operational Infrastructure Support program.
Funding Information:
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A/Prof Sciberras receives royalties from her book published through Elsevier: Sleep and ADHD: An Evidence-Based Guide to Assessment and Treatment. Prof Coghill has received honoraria from Medice, Novartis, Servier, and Takeda, and royalties from Oxford University Press and Cambridge University Press. A/Prof Becker has received grant funding from the Institute of Education Sciences (IES), U.S. Department of Education; National Institute of Mental Health (NIMH); and Cincinnati Children’s Research Foundation (CCRF) and has received book honoraria from Guilford Press. A/Prof Sciberras, Prof Coghill, and Prof Middeldorp are on the board of the Australian ADHD Professionals Association (AADPA). Prof Bellgrove is President of AADPA, which is leading the development of National Clinical Guidelines for ADHD in Australia. Prof Banaschewski served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Janssen, Medice, and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships.
Publisher Copyright:
© ©The Author(s) 2023.
PY - 2023/8
Y1 - 2023/8
N2 - Objective: To investigate the longitudinal associations between COVID-19 induced stress (related to COVID-19 restrictions/changes), attention-deficit/hyperactivity disorder (ADHD) symptoms, oppositional symptoms, and mental health outcomes (negative affect, anxiety, depression, and irritability) in children with ADHD during the COVID-19 pandemic. Method: Parents of 140 Australian children with ADHD (aged 5–17 years) completed an online survey in May 2020 during stay-at-home restrictions and 12-months later. Results: Baseline COVID-19 stress was associated with increased total ADHD symptom severity (β =.21, p =.007) and hyperactivity/impulsivity symptoms (β =.23, p =.002) at 12-months, after accounting for covariates (i.e., child age, gender, ADHD medication, socio-economic status, and baseline symptoms). Despite some indication of associations between baseline COVID-19 stress and 12-month oppositional symptoms and negative affect, these were attenuated when adjusting for baseline symptoms. Conclusions: The study provides initial evidence of the medium-term impacts of pandemic-related stress for children with ADHD.
AB - Objective: To investigate the longitudinal associations between COVID-19 induced stress (related to COVID-19 restrictions/changes), attention-deficit/hyperactivity disorder (ADHD) symptoms, oppositional symptoms, and mental health outcomes (negative affect, anxiety, depression, and irritability) in children with ADHD during the COVID-19 pandemic. Method: Parents of 140 Australian children with ADHD (aged 5–17 years) completed an online survey in May 2020 during stay-at-home restrictions and 12-months later. Results: Baseline COVID-19 stress was associated with increased total ADHD symptom severity (β =.21, p =.007) and hyperactivity/impulsivity symptoms (β =.23, p =.002) at 12-months, after accounting for covariates (i.e., child age, gender, ADHD medication, socio-economic status, and baseline symptoms). Despite some indication of associations between baseline COVID-19 stress and 12-month oppositional symptoms and negative affect, these were attenuated when adjusting for baseline symptoms. Conclusions: The study provides initial evidence of the medium-term impacts of pandemic-related stress for children with ADHD.
KW - ADHD
KW - COVID-19
KW - longitudinal
KW - mental health
KW - stress
UR - http://www.scopus.com/inward/record.url?scp=85160323317&partnerID=8YFLogxK
U2 - 10.1177/10870547231168334
DO - 10.1177/10870547231168334
M3 - Article
C2 - 37122232
AN - SCOPUS:85160323317
SN - 1087-0547
VL - 27
SP - 1065
EP - 1074
JO - Journal of Attention Disorders
JF - Journal of Attention Disorders
IS - 10
ER -
